Requires Drug Companies to Share Patent Information
Requires Drug Companies to Share Patent Information
IntroducedAugust 1, 2025
In Senate1 month ago
Intro
Senate
House
Pres
Waiting for a House floor vote.
It has cleared committee and can be brought up at any time, though no date is set.
HealthDrug safety, medical device, and laboratory regulationInflation and pricesIntellectual propertyManufacturingPrescription drugs
Why This Matters
This bill requires drug companies to share patent information with the Food and Drug Administration and the United States Patent and Trademark Office to ensure consistency in submissions.
If you are a drug manufacturer, you must now share patent information with federal agencies when applying for drug approvals.
Who this affects
Drug manufacturers · Pharmaceutical companies
What changes is this bill making?
1Drug companies must provide the Food and Drug Administration with information about patents related to their drugs.
2Companies must certify that the information they give to the Food and Drug Administration matches what they provide to the United States Patent and Trademark Office.
3This law applies to new drug applications submitted after the law is enacted and to certain amendments to existing applications.
